As of now, how many new crown vaccines are available in the world and put into use?
According to statistics, there are about 14 new crown vaccines in China and internationally, , which have been launched and put into use on a large scale. The countries that have developed and produced vaccines include China, the United States, the United Kingdom, Russia, India, Cuba , and Kazakhstan. The following is a introduction to you one by one.
First, let’s take a look at several new crown vaccines developed by foreign countries:
The United States mainly has the following three vaccines.
-, US Johnson & Johnson new crown vaccine: Janssen vaccine
Johnson & Johnson COVID-19
Technical route: adenovirus vector vaccine
R&D manufacturer: Johnson & Johnson Pharmaceuticals Company
On the marketplace: U.S. New York Stock Exchange
Johnson & Johnson Company Registration Address: New Jersey New Jersey
JPY stock price bull trend
2, United States Moderna's new crown vaccine
Modna's new crown vaccine
R&D manufacturer: was developed by Moderna and the National Institute of Allergy and Infectious Diseases.
Technical route: m-RNA
Modner Company, Company name: Moderna, Inc.
was registered and established on July 22, 2016 under the laws of Delaware .
on the market: NASDAQ Stock Exchange
Modner's stock trend is strong
3, US Pfizer /BioNTech new crown vaccine
Pfizer/BioNTech new crown vaccine
R&D manufacturer: developed by Pfizer Pharmaceuticals in the United States and BioNTech in Germany.
Vaccine technology route: m-RNA
Pfizer's stock price trend is slightly flat
Pfizer's English name: Pfizer Inc.
Pfizer Marketplace: New York Stock Exchange
Company profile:
Pfizer was established in accordance with the laws of the State of Delaware on June 2, 1942. The company is a global biopharmaceutical company based on research.
The three main vaccinations in the United States:
United States, Germany, Britain, Japan, France, Italy, Canada, Poland, South Korea, Netherlands,
Belgium Israel, Australia and other Western countries, Commonwealth member states, and European countries.
4, UK AstraZeneca COVID-19 vaccine Vaxzevria
AstraZeneca COVID-19 vaccine
R&D manufacturer: The COVID-19 vaccine jointly developed by Oxford University in the UK and AstraZeneca Pharmaceuticals in the UK.
Vaccine Technology Route: Adenovirus Vector Vaccine
Company Profile:
AstraZeneca Co., Ltd. is a global innovation-driven biopharmaceutical company with business in more than 100 countries. Its innovative drugs have been used by millions of patients around the world.
Company name: AstraZeneca Co., Ltd.
Registration address: England and Wales (England and Wales)
English name: Astrazeneca Plc
on the market: US NASDAQ Stock Exchange
AstraZeneca's stock price is in the filling market
AstraZeneca's new crown vaccine Vaxzevria is mainly vaccinated in the following countries:
UK, India , Brazil , Germany, France, Italy, Spain, Canada , Poland, South Korea, the Netherlands, Belgium and other European countries and member states of the Commonwealth.
5, domestically produced in India Covaxin COVID-19 vaccine
domestically produced in India Covaxin COVID-19 vaccine
R&D manufacturer: developed by Indian Bharat Biotechnology Company .
Vaccine technology route: inactivated vaccine
Bharat Biotech Introduction:
Headquarters address: Hyderabad
Chairman and President: Krihsna Ella
Temporarily, vaccinated with domestic production in India There are 7 countries with Covaxin COVID-19 vaccines as follows:
India, Iran , Mauritius , Paraguay , Comoros , Central African Republic,
6, Russia-Satellite V (Sputnik V)
Russia-Satellite V Sputnik V
R&D manufacturer: developed by the Russian Gamale National Epidemiology and Microbiology Research Center
Vaccine Technology Route: Adenovirus Vector Vaccine
Russia -The main countries for using the Satellite V COVID-19 vaccine:
Russia, India, Mexico , Argentina , UAE , Philippines , Hungary , Kazakhstan,
Serbia , Egypt, Jordan , Venezuela , Mongolia, Iraq , Albania, Palestine ,
Belarus , Central Asian countries and Eastern European countries.
7, Russian EpiVacCorona COVID-19 vaccine
Russian EpiVacCorona COVID-19 vaccine
R&D and manufacture: developed by Russia's "vector" Virology and National Science Center for Biotechnology.
Vaccine Technical Route: is a synthetic peptide vaccine. It consists of artificially synthesized viral protein fragments, that is, peptides. The human immune system learns how to recognize and neutralize viruses by synthesizing peptides.
Russian EpiVacCorona COVID-19 vaccine is temporarily only used in Russia.
8, Cuba Abdala new crown vaccine
The first new crown vaccine developed independently by Latin American countries. In the drama created by Cuban national hero José Martí, the young hero fighting to protect the country is called Abdala. Abdala symbolizes passionate patriotism, moving forward no matter how powerful the opponent is.
Abdala COVID-19 vaccine
Vaccine technology route: This Cuban vaccine is neither a vector vaccine nor uses mRNA technology, but a so-called protein vaccine, which connects with the spike protein of the virus itself, thereby stimulating an immune response. Cuban scientists use yeast cells for research.
R&D and Manufacturer: Cuban state-owned biopharmaceutical company BioCubaFarma
abdala vaccine is temporarily only undergoing large-scale vaccination in Cuba, but Venezuela has signed a purchase contract.
9, Kazakhstan QAZVAC vaccine
Kazakhstan QAZVAC vaccine
R&D and manufacturer: Kazakhstan Institute of Biosafety
Vaccination technology route: inactivated vaccine
Main countries of vaccination: Kazakhstan
Let’s take a look at the types of domestic vaccines.
1, Sinopharm Group's new coronavirus vaccine
vaccine development technology route: inactivated vaccine.
2, the new coronavirus vaccine of Sinopharm Group China Biologics Wuhan Institute of Biological Products
also belongs to the second new coronavirus vaccine of Sinopharm Group .
vaccine development technology route: inactivated vaccine.
3, China Beijing Sinovac China Biotechnology Co., Ltd.'s new crown vaccine (CoronaVac, krl href )
ker href
vaccine development technology route: inactivated vaccine.
R&D manufacturer: China Beijing Sinovac Zhongwei Biotechnology Co., Ltd.
4, CanSino new coronavirus vaccine - CanSino Virus
g Wissa
Vaccine R&D technical route: adenovirus vector vaccine.
R&D and Manufacturer: A shares Science and Technology Innovation Board listed company CanSino Biologics Co., Ltd.
Stock code: 688185
CanSino Stock Price Trend
5, Zhifei Biologics Recombinant novel coronavirus vaccine Zhikeweid (CHO cells).
Zhikeweide
R&D technology route: recombinant coronavirus vaccine (CHO cells)
R&D manufacturer: Chongqing Zhifei Bioproducts Co., Ltd.
Zhifei Bio stock code: 300122
or above five domestic vaccines are mainly vaccinated by the following countries.
China domestic: Four vaccines are vaccinated in various places at the same time.
Internationally use Beijing Sinovac vaccine There are the following 26 countries:
Brazil, Uruguay , Ecuador , Singapore , Turkey , Indonesia , Mexico
Chile , Colombia, Philippines , Thailand, Malaysia , Azerbaijan, Ukraine, El Salvador
Tunisia , Oman , Albania, Sudan , Bosnia , Bosnia , Libya , East Timor , Turkish Republic of North Cyprus, Armenia, Benin, Djibouti
There are the following 42 countries that use Sinopharm Beijing COVID-19 vaccine .
Argentina, Serbia, Jordan, Morocco , Iran , Sri Lanka, Vietnam,
Bangladesh , Hungary, Peru , Venezuela, Mongolia , Nepal, Bolivia ,
Balin, Lebanon , Zimbabwe , , Laos , Iraq , Afghanistan , Mauritius ,
Moldova , Senegal , Maldives , Mozambique , Niger , Montenegro , Zambia ,
Equatorial Guinea , Mauritania , Kyrgyzstan, Cameroon, Namibia, Belize
Seychelles, Brunei, Comoros, Gabon , Papua New Guinea, Dominic, Guinea-Bissau, Chad
Countries that use Sinopharm Beijing and Sinovac vaccines at the same time:
Pakistan , UAE, Cambodia , Dominican, Egypt, Paraguay, North Macedonia, Somalia
Here, we have to mention a German biopharmaceutical company, which is called BioNTech .
BioNTech's information is as follows:
Company name: BioNTech SE
Registration Country: Federal Republic of Germany (Federal Republic of Germany)
Industry: Biotech
BioNTech SE was established on June 2, 2008. The company combines decades of immunology, cutting-edge treatment platforms, and groundbreaking research on a variety of patient analytics and bioinformatics tools to develop individualized immunotherapy targeting cancer and other diseases. The company leverages powerful new therapeutic mechanisms, leveraging various biological targets, leveraging the power of each patient’s immune system to address the unique molecular characteristics of each patient’s underlying disease.
Listing date: 2019-10-10
Marketing place: US NASDAQ Stock Exchange
BioNTech's stock price has risen all the way
So far, Germany's BioNTech has cooperated with companies in the following countries to produce new crown vaccines with a technical route of m-RNA, and it is in a leading position in the international field in m-RNA technology.
1, a new crown vaccine "FuBitai" that cooperates with China's A-share listed company Fosun Pharma to produce m-RNA.
According to the latest news, the listing date of Fubitai produced by the Chinese and German joint venture is approaching.
2, cooperates with the US listed company Pfizer Pharmaceutical to produce the new crown vaccine for m-RNA.
Pfizer's new crown vaccine is one of the earliest new crown vaccines to be launched in the world. has been widely vaccinated in Western countries.
summary: The above are 14 new crown vaccines that have been launched in China and most countries in the world and are being vaccinated on a large scale. There are 7 countries that have developed and produced vaccines in total: China, the United States, Russia, the United Kingdom, India, Cuba, Kazakhstan,
There are 7 top listed companies in the biopharmaceutical field: Pfizer, Moderna, Johnson & Johnson, AstraZeneca, BioNTech, CanSino, and Zhifei Bio.
Two small countries that are not conspicuous in the world, Cuba and Kazakhstan have unexpectedly successfully developed their own domestic vaccines and have made their own efforts to fight the new crown epidemic around the world.
believes that with the joint efforts of people from all over the world, mankind will definitely be able to ultimately defeat the new crown epidemic.
Thank you everyone!
